AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) major shareholder Everest Hill Group Inc. sold 4,789 shares of AdaptHealth stock in a transaction that occurred on Wednesday, January 18th. The shares were sold at an average price of $22.00, for a total transaction of $105,358.00. Following the sale, the insider now owns 13,445,008 shares of the company's stock, valued at $295,790,176. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.

Everest Hill Group Inc. also recently made the following trade(s):

• On Thursday, January 12th, Everest Hill Group Inc. sold 340,000 shares of AdaptHealth stock. The stock was sold at an average price of $20.00, for a total transaction of $6,800,000.00.
• On Tuesday, January 10th, Everest Hill Group Inc. sold 200,000 shares of AdaptHealth stock. The stock was sold at an average price of $20.00, for a total transaction of $4,000,000.00.
• On Friday, November 11th, Everest Hill Group Inc. sold 23,583 shares of AdaptHealth stock. The stock was sold at an average price of $23.00, for a total transaction of $542,409.00.
• On Tuesday, November 1st, Everest Hill Group Inc. sold 45,999 shares of AdaptHealth stock. The stock was sold at an average price of $23.00, for a total transaction of $1,057,977.00.
• On Friday, October 28th, Everest Hill Group Inc. sold 10,437 shares of AdaptHealth stock. The shares were sold at an average price of $23.00, for a total transaction of $240,051.00.
• On Wednesday, October 26th, Everest Hill Group Inc. sold 165,968 shares of AdaptHealth stock. The shares were sold at an average price of $22.00, for a total transaction of $3,651,296.00.
• On Monday, October 24th, Everest Hill Group Inc. sold 14,605 shares of AdaptHealth stock. The shares were sold at an average price of $22.00, for a total transaction of $321,310.00.

AdaptHealth Stock Down 2.8 %

Shares of NASDAQ:AHCO traded down $0.60 during midday trading on Friday, reaching $21.03. The company's stock had a trading volume of 565,878 shares, compared to its average volume of 646,929. The firm has a 50 day moving average of $20.81 and a 200-day moving average of $20.79. The firm has a market capitalization of $2.83 billion, a P/E ratio of 48.84, a PEG ratio of 0.47 and a beta of 0.64. The company has a quick ratio of 1.08, a current ratio of 1.35 and a debt-to-equity ratio of 1.00. AdaptHealth Corp. has a 12-month low of $11.40 and a 12-month high of $27.48.

Institutional Trading of AdaptHealth

A number of hedge funds and other institutional investors have recently modified their holdings of AHCO. Trexquant Investment LP purchased a new position in AdaptHealth in the second quarter worth about $626,000. Resource Consulting Group Inc. purchased a new position in AdaptHealth in the 3rd quarter worth approximately $2,646,000. TCW Group Inc. purchased a new position in AdaptHealth in the 3rd quarter worth approximately $503,000. Kennedy Capital Management Inc. raised its holdings in AdaptHealth by 10.6% in the 2nd quarter. Kennedy Capital Management Inc. now owns 629,106 shares of the company's stock worth $11,349,000 after acquiring an additional 60,371 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its holdings in AdaptHealth by 10.3% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 47,809 shares of the company's stock worth $862,000 after acquiring an additional 4,457 shares during the last quarter. 86.33% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on AHCO. Canaccord Genuity Group boosted their price objective on shares of AdaptHealth from $26.00 to $28.00 and gave the company a "buy" rating in a research report on Wednesday, November 9th. SVB Leerink boosted their price objective on shares of AdaptHealth from $29.00 to $30.00 and gave the company an "outperform" rating in a research report on Thursday, November 10th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $27.67.

AdaptHealth Company Profile

(Get Rating)

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Further Reading

• Get a free copy of the StockNews.com research report on AdaptHealth (AHCO)
• Does Old Dominion Show That Trucking Is Hitting The Brakes?
• Nordstrom Puts Fear Of Markdowns Into Retail Sector
• Exxon Mobil Stock: Within Striking Distance Of Buy Point
• High-Dividend-Yielding BHP Sees China Driving '23 Growth
• Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.